Thioridazine

Schizophrenia Treatment

Thioridazine is primarily prescribed for the management of schizophrenia. It belongs to a class of medications known as conventional antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Second-Line Therapy

Because thioridazine carries a risk of serious heart rhythm problems, it is generally used as a second-line treatment. This means it is typically only prescribed when:

• At least two other antipsychotic medications have failed to improve symptoms.
• Other treatments have caused side effects that the patient cannot tolerate.

The goal of treatment is to help reduce symptoms such as hallucinations, delusions, and disorganized thinking, allowing the individual to function more effectively in daily life.

Mechanism of Action

Thioridazine belongs to a class of medications known as phenothiazine antipsychotics. It works primarily by blocking dopamine receptors in the brain. Dopamine is a chemical messenger, or neurotransmitter, that plays a significant role in regulating mood, behavior, and how the brain processes information.

In people with schizophrenia, certain brain pathways may have overactive dopamine signaling. By attaching to and blocking these receptors, thioridazine helps to:

• Reduce hallucinations, such as hearing or seeing things that are not there
• Decrease delusions, which are strong beliefs that are not based in reality
• Improve disorganized thinking and behavior

In addition to its effects on dopamine, thioridazine also interacts with other chemical systems in the body, including those involving acetylcholine, histamine, and norepinephrine. These interactions contribute to the medication's overall impact on the central nervous system.

Common Side Effects

• Drowsiness or dizziness
• Dry mouth
• Blurred vision
• Constipation
• Nausea or vomiting
• Stuffy nose
• Weight gain
• Swelling in the hands or feet
• Breast enlargement or discharge
• Changes in menstrual cycles

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Uncontrolled muscle movements, especially in the face, tongue, or jaw
• Severe muscle stiffness, high fever, sweating, and confusion
• Fast, slow, or irregular heartbeat
• Vision changes, such as blurred vision or difficulty seeing in low light
• Yellowing of the skin or eyes
• Seizures
• Difficulty urinating or swallowing
• Extreme restlessness or tremors

Boxed Warning: Heart Rhythm Risks

Thioridazine has been shown to prolong the QT interval, which is a measure of the heart's electrical cycle. This can lead to a life-threatening heart rhythm disorder and sudden death. Due to this risk, thioridazine is generally reserved for the treatment of schizophrenia in patients who have not responded to or cannot tolerate at least two other antipsychotic medications.

Dementia-Related Psychosis

Older adults with dementia-related psychosis treated with antipsychotic medications are at an increased risk of death. Thioridazine is not approved for the treatment of dementia-related psychosis.

Contraindications and Interactions

Thioridazine should not be used in combination with certain other medications that also affect the heart rhythm or interfere with the body's ability to process thioridazine. This includes:

• Specific antidepressants such as fluoxetine, paroxetine, and fluvoxamine.
• Certain heart rhythm medications (antiarrhythmics).
• Other drugs known to prolong the QT interval.

It is also contraindicated for individuals with a history of certain heart conditions, including congenital long QT syndrome, a history of cardiac arrhythmias, or significant heart disease.

Neuroleptic Malignant Syndrome (NMS)

A potentially fatal symptom complex known as NMS has been reported with antipsychotic drugs. Signs include high fever, muscle rigidity, altered mental status, and evidence of autonomic instability, such as irregular pulse or blood pressure.

Tardive Dyskinesia

The use of thioridazine may lead to tardive dyskinesia, a condition characterized by involuntary, repetitive body movements. The risk is highest with long-term use and in older adults, particularly women. The condition may be irreversible even if the medication is stopped.

Additional Precautions

• Vision Changes: High doses of thioridazine have been associated with pigmentary retinopathy, which can cause blurred vision or impaired night vision.
• Low Blood Pressure: Patients may experience a sudden drop in blood pressure, especially when moving from a sitting or lying position to standing.
• Seizure Risk: This medication may lower the seizure threshold, increasing the risk of seizures in susceptible individuals.
• Blood Cell Counts: There is a risk of severe decreases in white blood cell counts, such as agranulocytosis or leukopenia.
• CNS Depression: Combining thioridazine with alcohol or opioids can lead to profound sedation, respiratory distress, coma, or death.

Pregnancy

The safety of thioridazine during pregnancy has not been established. It is generally recommended for use only when the potential benefits to the mother justify the potential risks to the developing fetus.

Newborns exposed to antipsychotic medications during the third trimester of pregnancy may be at risk for extrapyramidal or withdrawal symptoms after delivery. These symptoms can vary in severity and may include:

• Agitation or irritability
• Increased or decreased muscle tone
• Tremors
• Excessive sleepiness
• Difficulty breathing
• Feeding problems

If you are pregnant or planning to become pregnant, discuss the risks and benefits of thioridazine with your healthcare provider to determine the best treatment plan.

Breastfeeding

It is not known whether thioridazine is excreted in human breast milk. Because many drugs are passed through milk and there is a potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue breastfeeding or discontinue the medication. Patients should consult with their healthcare provider to weigh the risks to the infant against the importance of the drug to the mother.

Available Forms

Thioridazine is currently available in the following form:

• Oral Tablet: This medication is a solid tablet intended to be swallowed.

Your healthcare provider will determine the appropriate schedule for taking this medication. It is important to follow the specific instructions provided on your prescription label.

FDA Approval and Indications

Thioridazine is approved by the U.S. Food and Drug Administration (FDA) for the management of schizophrenia. Due to significant safety concerns, it is indicated only for patients who fail to show an acceptable response to at least two other antipsychotic medications.

Boxed Warning

The FDA has issued a Boxed Warning for thioridazine because it can cause a dose-related prolongation of the QTc interval. This condition affects the heart's electrical cycle and can lead to:

• Torsade de pointes, a life-threatening heart rhythm.
• Serious ventricular arrhythmias.
• Sudden death.

Regulatory Restrictions

Because of the risk of sudden death, thioridazine is classified as a last-resort treatment. It is contraindicated in patients with certain heart conditions, such as a history of cardiac arrhythmias or a long QTc interval, and in those taking other drugs that inhibit its metabolism or also prolong the QTc interval.

Safety Communications

General FDA safety communications warn of increased risks when combining antipsychotic medications with opioids, which can result in profound sedation, respiratory depression, coma, and death.

Withdrawal Symptoms

If thioridazine is stopped abruptly, especially after long-term use or high doses, physical withdrawal symptoms may occur. These symptoms typically include:

• Nausea and vomiting
• Stomach pain
• Dizziness
• Tremors or shakiness

These symptoms are generally temporary but can be uncomfortable. To avoid these effects, healthcare providers usually recommend a gradual reduction in dosage rather than stopping the medication all at once.

Medical Supervision

It is important not to stop taking thioridazine or change the dose without consulting a doctor. A healthcare professional will create a tapering schedule to slowly lower the dose, which helps the body adjust and minimizes the risk of withdrawal reactions. If symptoms do occur during a dose reduction, they should be reported to a healthcare provider immediately.